Africa: Lassa Fever – Global Health Coalition Invests $250m in Vaccine Research

The new research led by the Nigeria Centre for Disease Control (NCDC), CEPI and other partners is scheduled to commence in October.

The Coalition for Epidemic Preparedness Innovations (CEPI) said it has invested over $250 million in Lassa fever research since 2017 for the development of a vaccine against the deadly disease.

The CEPI’s Director of Epidemiology and Data Science, Gabrielle Breugelmans, disclosed this on Wednesday at the inauguration of the Enable 1.5 cohort study in Abuja.

Enable 1.5…